InsidersTradesSigma
Follow the 쎌바이오텍 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 쎌바이오텍 has logged 1 reports. Market capitalisation: €113.4bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: 쎌바이오텍. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.